Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: Restricted array of mutations associated with drug resistance

Journal of Infectious Diseases

Volumn 173, Issue 1, 1996, Pages 196-202

  Musser, James M ^a   Kapur, Vivek ^b   Williams, Diana L ^c   Kreiswirth, Barry N ^c   Van Soolingen, Dick ^c   Van Embden, Jan D A ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CATALASE; ETHAMBUTOL; ISONIAZID; PEROXIDASE; RIFAMPICIN; STREPTOMYCIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DNA SEQUENCE; GENE LOCUS; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BASE SEQUENCE; CATALASE; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; GENES, BACTERIAL; HUMANS; ISONIAZID; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; PEROXIDASE; PEROXIDASES; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS;

EID: 0030042509     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.1.196     Document Type: Article

References (26)

1. Bloom BR, Murray CJL. Tuberculosis: commentary on a reemergent killer. Science 1992;257:1055-64.
2. Bloch AB, Cauthen GM, Onorato IM, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994;271:665-71.
3. Musser JM. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 1995;8:496-514.
4. Middlebrook G. Isoniazid-resistance and catalase activity of tubercle bacilli. Am Rev Tuberc 1954;69:471-2.
5. Hedgecock LAV, Faucher IO. Relation of pyrogallol-peroxidative activity to isoniazid resistance in Mycobacterium tuberculosis. Am Rev Tuberc 1957;75:670-4.
6. Zhang Y, Heym B, Allen B, Young D, Cole S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992;358:591-3.
7. Heym B, Zhang Y, Poulet S, Young D, Cole ST. Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis. J Bacteriol 1993; 175:4255-9.
8. Morris SL, Nair J, Rouse DJ. The catalase-peroxidase of Mycobacterium intracellulare: nucleotide sequence analysis and expression in Esclierichia coli. J Gen Microbiol 1992;138:2363-70.
9. Stoeckle MY, Guan L, Riegler N, et al. Catalase-peroxidase gene sequences in isoniazid-sensitive and -resistant strains of Mycobacterium tuberculosis from New York City. J Infect Dis 1993;168:1063-5.
10. Kapur V, Li LL, Hamrick MR, et al. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med 1995;119:131-8.
11. Altamirano M, Marostenmaki J, Wong A, FitzGerald M, Black WA, Smith JA. Mutations in the catalase-peroxidase gene from isoniazid-resistant Mycobacterium tuberculosis isolates. J Infect Dis 1994;169:1162-5.
12. Cockerill FR III, Uhl JR, Temesgen Z, et al. Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance. J Infect Dis 1995;171:240-5.
13. Heym B, Alzari PM, Honore N, Cole ST. Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol 1995;15:235-45.
14. Morris S, Han Bai G, Suffys P, Portillo-Gomez L, Fairchok M, Rouse D. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis 1995;171:954-60.
15. Banerjee A, Dubnau E, Quemard A, et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994;263:227-30.
16. Dessen A, Quemard A, Blanchard JS, Jacobs WR Jr, Sacchettini JC. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science 1995;267:1638-41.
17. Kapur V, Li LL, Iordanescu S, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase β subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 1994;32:1095-8.
18. Williams DL, Waguespack C, Eisenach K, et al. Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob Agents Chemother 1994;38:2380-6.
19. Inderlied CB, Salfinger M. Antimicrobial agents and susceptibility tests: mycobacteria. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology, 1995:1385-404.
20. van Embden JDA, Cave MD, Crawford JT, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31:406-9.
21. Kapur V, Whittam TS, Musser JM. Is Mycobacterium tuberculosis 15,000 years old? J Infect Dis 1994;170:1348-9.
22. Wilson TM, de Lisle GW, Collins DM. Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis. Mol Microbiol 1995;15:1009-15.
23. Loewen PC, Switala J, Smolenski M, Triggs-Raine BL. Molecular characterization of three mutations in katG affecting the activity of hydroperoxidase I of Escherichia coli. Biochem Cell Biol 1990;68:1037-44.
24. Finzel BC, Poulos TL, Kraut J. Crystal structure of yeast cytochrome c peroxidase refined at 1.7 - a resolution. J Biol Chem 1984;259: 13027-36.
25. Grantham R, Gautier C, Gouy M, Mercier R, Pave A. Codon catalog usage and the genome hypothesis. Nucleic Acids Res 1980;8:r49-r62.
26. Gouy M, Gautier C. Codon usage in bacteria: correlation with gene expressivity. Nucleic Acids Res 1982;10:7055-74.